News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Raffaele Colombo Highlights IND Approval of VEGF-Targeting ADC YL242
Raffaele Colombo/LinkedIn
May 15, 2025, 11:42

Raffaele Colombo Highlights IND Approval of VEGF-Targeting ADC YL242

Raffaele Colombo, Associate Director, Medicinal Chemistry at Zymeworks Inc., shared on X about a recent paper by Tongtong Xue et al. published in AACR Journals:

“IND approved by Chinese NMPA for YL242, a non-internalizing ADC targeting soluble VEGF, with a TOPO1i payload, and DAR=4.
They recently presented a poster on its preclinical development at AACR25 in Chicago.”
Raffaele Colombo Raffaele Colombo

Title: Abstract 3140: Preclinical development of YL242, a non-internalized antibody-drug conjugate (ADC) targeting soluble VEGF for treatment of solid tumors

Authors: Tongtong Xue, Wei Lian, Qing Zong, Chun Deng, Qigang Liu, Peng Zou, Jiaqiang Cai

Read Full Article.

Raffaele Colombo

More posts featuring Raffaele Colombo.

AACR Journals AACR25 cancer Chun Deng Jiaqiang Cai OncoDaily Oncology Peng Zou Qigang Liu Qing Zong Raffaele Colombo Tongtong Xue Wei Lian
Special Coverage
Positive
Jul 1, 2025, 16:47
Nation-Leading Heart Surgery Milestone - St. Elizabeth Healthcare
Societies
Jul 1, 2025, 16:16
Latest Research Findings in GI Cancers from ESMO Ambassadors
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer